What are Aurinia Pharmaceuticals's profit margins?

Gross margin is 89.7% and operating margin is 41.7%, with a 100.0% net margin.

Where does Aurinia Pharmaceuticals's income statement data come from?

Every line is extracted from Aurinia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Aurinia Pharmaceuticals AUPH Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$298.3M+20.6%	$283.06M+20.4%	$265.81M+20.6%	$260.11M+25.6%	$247.3M+29.2%
Total cost of revenue	$30.6M+5.2%	$32.67M+15.6%	$29.42M+4.7%	$27.28M-5.4%	$29.07M+35.3%
Gross profit	$267.7M+22.7%	$250.39M+21.0%	$236.39M+22.9%	$232.84M+30.6%	$218.23M+28.4%
Gross margin	89.7%+1.5pp	88.5%+0.5pp	88.9%+1.7pp	89.5%+3.4pp	88.2%-0.5pp
Research and development	$34.23M+63.2%	$32.51M+56.4%	$29.72M+29.7%	$24.33M-27.3%	$20.98M-50.1%
General and administrative	$103.48M-28.5%	$101.79M-40.8%	$109.57M-40.8%	$125.76M-34.0%	$144.67M-24.9%
Total costs & expenses	$173.81M-19.9%	$178.14M-25.7%	$195.8M-22.6%	$208.1M-22.3%	$216.88M-18.7%
Operating income	$124.49M+309%	$104.91M+2,338%	$70.01M+314%	$52.01M+186%	$30.41M+140%
Operating margin	41.7%+29.4pp	37.1%+39.1pp	26.3%+41.2pp	20%+49.3pp	12.3%+51.7pp
Interest expense	$4.28M-7.4%	$4.33M-10.4%	$4.43M-11.4%	$4.54M-12.6%	$4.62M+13.8%
Income before income taxes	$133.73M+220%	$114.16M+1,433%	$79.64M+495%	$62.49M+230%	$41.81M+168%
Income tax expense	-$164.48M—	-$173.05M—	——	——	——
Net income	$298.21M+648%	$287.2M+4,893%	$77.84M+445%	$60.64M+220%	$39.85M+164%
Net margin	100%+83.9pp	101.5%+99.0pp	29.3%+39.5pp	23.3%+47.6pp	16.1%+48.8pp
Diluted earnings per share	$2.17+675%	$2.08+4,060%	$0.56+473%	$0.43+226%	$0.28+165%
EBITDA	$143.9M+189%	$124.36M+743%	$89.45M+689%	$71.48M+258%	$49.87M+181%
EBITDA margin	48.2%+28.1pp	43.9%+37.7pp	33.7%+40.5pp	27.5%+49.3pp	20.2%+52.4pp
EBIT	$124.49M+309%	$104.91M+2,338%	$70.01M+314%	$52.01M+186%	$30.41M+140%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Aurinia Pharmaceuticals's profit margins?: Gross margin is 89.7% and operating margin is 41.7%, with a 100.0% net margin.
Where does Aurinia Pharmaceuticals's income statement data come from?: Every line is extracted from Aurinia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.